Aristolochic Acid Nephropathy
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
49
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Dysmorphic features
|
disease |
|
Congenital Abnormality
|
439
|
617
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Beckwith-Wiedemann Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
107
|
84
|
0.020 |
None |
1.000 |
2 |
|
1992 |
2017 |
Tumor Promotion
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
170
|
2
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Schizophrenia, Childhood
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
33
|
20
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Influenza due to Influenza A virus subtype H1N1
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
44
|
65
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Impaired cognition
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1630
|
348
|
0.030 |
None |
0.667 |
3 |
|
2005 |
2012 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Neurodevelopmental Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
535
|
14
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Behavior Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
77
|
4
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Thrombocytopenia
|
phenotype |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
592
|
110
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Cognition Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
607
|
47
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2010 |
Central hypothyroidism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
35
|
3
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Craniofacial Abnormalities
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Congenital Abnormality
|
234
|
4
|
0.310 |
None |
1.000 |
1 |
|
2010 |
2010 |
Secondary hypothyroidism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
47
|
2
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Abnormal behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
910
|
121
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Congenital Abnormality
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
1098
|
73
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Developmental Disabilities
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
355
|
19
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Muscle Weakness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases; Nervous System Diseases
|
Sign or Symptom
|
536
|
87
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Paresis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
216
|
49
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Supravalvular aortic stenosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
23
|
38
|
0.110 |
None |
1.000 |
1 |
|
2000 |
2000 |
Developmental symptoms
|
phenotype |
|
Sign or Symptom
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Congenital exomphalos
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
235
|
|
0.100 |
None |
|
0 |
|
|
|